-
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Wednesday, May 11, 2022 - 9:37am | 1893Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Veru Suggested By FDA To Submit Emergency Use Request For Sabizabulin In COVID-19 In a Pre-EUA meeting, the FDA said Veru Inc (NASDAQ: VERU) should submit a request for FDA emergency...
-
Inovio Jumps After Announcing Successful Zika, MERS Vaccine Studies
Thursday, February 23, 2017 - 12:46pm | 442Read More...Inovio Pharmaceuticals, Inc. (NASDAQ: INO) said Thursday it’s observed a 100-percent antibody response in a phase I study for a Zika virus vaccine and a 92 percent antibody response in a phase I study for a MERS vaccine. The findings were presented at a Coalition for Epidemic Preparedness...
-
Inovio Reports Encouraging Results From Preclinical Testing Of Zika Virus Vaccine
Wednesday, February 17, 2016 - 11:52am | 253Read More...Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO) were trading higher by more than 5 percent on Wednesday after the company announced that preclinical testing of SynCon, a vaccine for the Zika virus, induced "robust and durable immune responses." Inovio is developing a vaccine for...
